The association of vitamin D deficiency with non-alcoholic fatty liver disease

Clinics

Volumn 69, Issue 8, 2014, Pages 542-546

  Küçükazman, Metin ^a   Ata, Naim ^a   Dal, Kürşat ^a   Yeniova, Abdullah Özgür ^a   Kefeli, Ayşe ^a   Basyigit, Sebahat ^a   Aktas, Bora ^a   Akin, Kadir Okhan ^a   Aǧladioǧlu, Kadir ^a   üre, Öznur Sari ^a   Topal, Firdes ^b   Nazligül, Yaşar ^a   Beyan, Esin ^a   Ertugrul, Derun Taner ^a  

^a Kecioren Teaching and Research Hospital   (Turkey)

^b Ankara Oncology Teaching and Research Hospital   (Turkey)

Author keywords

Hepatosteatosis; Non Alcoholic Fatty Liver Disease; Vitamin D

Indexed keywords

C PEPTIDE; CREATININE; GLUCOSE BLOOD LEVEL; INSULIN; VITAMIN D;

ADULT; ALBUMINURIA; ANALYSIS; BLOOD; COMPLICATION; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; OUTPATIENT; REGRESSION ANALYSIS; SEASON; URINE; VITAMIN D DEFICIENCY;

ADULT; ALBUMINURIA; BLOOD GLUCOSE; C-PEPTIDE; CREATININE; FASTING; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OUTPATIENTS; REGRESSION ANALYSIS; SEASONS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84906277596     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2014(08)07     Document Type: Article

References (17)

1. Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol. 2010;106(7):963-8, http://dx.doi.org/10.1016/j.amjcard. 2010.05.027.
2. Chagas CE, Borges MC, Martini LA, Rogero MM. Focus on vitamin D, inflammation and type 2 diabetes. Nutrients. 2012;4(1):52-67, http://dx. doi.org/10.3390/nu4010052.
3. Zhou QG, Hou FF, Guo ZJ, Liang M, Wang GB, Zhang X. 1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells. Diabetes Metab Res Rev. 2008; 24(6):459-64, http://dx.doi.org/10.1002/dmrr.873.
4. McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis. 2004;8(3):521-33, viii, http://dx.doi.org/10.1016/j.cld.2004.04.004.
5. Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes. 2005;54(12):3541-6, http://dx. doi.org/10.2337/diabetes.54.12.3541.
6. Dasarathy J, Periyalwar P, Allampati S, Bhinder V, Hawkins C, Brandt P, et al. Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver Int. 2013. doi: 10.1111/liv.12312.
7. Li L, Zhang L, Pan S, Wu X, Yin X. No significant association between vitamin D and nonalcoholic fatty liver disease in a Chinese population. Dig Dis Sci. 2013;58(8):2376-82, http://dx.doi.org/10.1007/s10620-013-2658-1.
8. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed). 1986;292(6512):13-5, http://dx.doi.org/10.1136/bmj.292.6512.13.
9. Jablonski KL, Jovanovich A, Holmen J, Targher G, McFann K, Kendrick J, et al. Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2013;23(8):792-8, http://dx.doi.org/10.1016/j.numecd. 2012.12.006.
10. Rhee EJ, Kim MK, Park SE, Park CY, Baek KH, Lee WY, et al. High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome. Endocr J. 2013; 60(6):743-52, http://dx.doi.org/10.1507/endocrj.EJ12-0387.
11. Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G, et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2007;17(7):517-24, http://dx.doi.org/10.1016/j. numecd.2006.04.002.
12. Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, Morini S, et al. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med. 2011;9:85, http://dx.doi.org/10.1186/ 1741-7015-9-85.
13. Sazci A, Akpinar G, Aygun C, Ergul E, Senturk O, Hulagu S. Association of apolipoprotein E polymorphisms in patients with non-alcoholic steatohepatitis. Dig Dis Sci. 2008;53(12):3218-24, http://dx.doi.org/10. 1007/s10620-008-0271-5.
14. Huebbe P, Nebel A, Siegert S, Moehring J, Boesch-Saadatmandi C, Most E, et al. APOE epsilon4 is associated with higher vitamin D levels in targeted replacement mice and humans. FASEB J. 2011;25(9):3262-70, http://dx.doi.org/10.1096/fj.11-180935.
15. Cohen-Lahav M, Shany S, Tobvin D, Chaimovitz C, Douvdevani A. Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels. Nephrol Dial Transplant. 2006;21(4):889-97.
16. Garciade Leon Mdel C, Montfort I, Tello Montes E, Lopez Vancell R, Olivos Garcia A, Gonzalez Canto A, et al. Hepatocyte production of modulators of extracellular liver matrix in normal and cirrhotic rat liver. Exp Mol Pathol. 2006;80(1):97-108, http://dx.doi.org/10.1016/j.yexmp.2005.03.008.
17. Petta S, Camma C, Scazzone C, Tripodo C, Di Marco V, Bono A, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology. 2010;51(4):1158-67.